PMA device
Harmony TPV System
Medtronic, Inc. · Pulmonary Valve Prosthesis Percutaneously Delivered (NPV, ) · First FDA decision Mar 26, 2021, newest Mar 6, 2026Congenital heart disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
Breakthrough-designated
Device trials
2
Naming "Harmony TPV"
MAUDE reports
0
Brand "Harmony TPV", since 2015
PubMed studies
16
Mentioning "Harmony TPV"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Harmony TPV System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- Harmony TPV SystemPMA supplement
P200046-S048 · Decided Mar 6, 2026 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: Pulmonary valve prosthesis percutaneously delivered (NPV) · Cardiology
- Harmony TPV SystemPMA supplement
P200046-S031 · Decided Mar 22, 2024 · 28 days after receipt · Normal 180 Day Track No User Fee
Device type: Pulmonary valve prosthesis percutaneously delivered (NPV) · Cardiology
- Harmony TPV SystemPMA supplement
P200046-S023 · Decided Nov 3, 2023 · 28 days after receipt · Normal 180 Day Track No User Fee
Device type: Pulmonary valve prosthesis percutaneously delivered (NPV) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Harmony TPV", any status and sponsor, newest update first.
- Harmony TPV Post-Approval StudyActive, not recruiting
Medtronic CardiovascularPublic (MDT)
NCT05077774 · 174 participants · Start Oct 25, 2021 · Primary completion Nov 2026
Device: Harmony TPV System · For: Congenital Heart Disease; Tetrology of Fallot; RVOT Anomaly and 1 more
Sites: Birmingham, Alabama; Los Angeles, California; Aurora, Colorado · 20 sites in all
- The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical StudyActive, not recruiting
Medtronic Heart ValvesPublic (MDT)
NCT02979587 · 86 participants · Start Jan 2017 · Primary completion Jul 17, 2020
Device: Harmony TPV System · For: Congenital Heart Disease; Tetrology of Fallot; RVOT Anomaly and 1 more
Sites: Los Angeles, California; Palo Alto, California; New Haven, Connecticut · 12 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Harmony TPV", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NPV
2,196 reports: 375 malfunction, 1,749 injury, 72 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Medtronic Harmony Delivery Catheter SystemOpen, Classified
Medtronic Heart Valves Division
Z-2624-2026 · Started May 22, 2026 · Posted by FDA Jul 2, 2026
Reason given: Devices containing inner shaft assemblies from specific manufacturing lots may have an increased potential for distal tip detachment from the delivery system under certain procedural or anatomical conditions due to a manufacturing issue.
Cause as FDA categorized it: Process control · Device type: Pulmonary Valve Prosthesis Percutaneously Delivered (NPV)
- Harmony Delivery Catheter System. Part of the Harmony Transcatheter Pulmonary Valve (TPV) Replacement Implantation System.Open, Classified
Z-0927-2022 · Started Mar 2, 2022 · Posted by FDA Apr 18, 2022
Reason given: There is potential for the capsule bond to break during the procedure.
Cause as FDA categorized it: Under Investigation by firm · Device type: Pulmonary Valve Prosthesis Percutaneously Delivered (NPV)
Published research
The most relevant PubMed records for "Harmony TPV"[tiab]. The summary above synthesizes these.
- Percutaneous Pulmonary Valve Implantation.
Giugno L, Faccini A, Carminati M · Korean Circ J · 2020Review
- Patient Screening for Self-Expanding Percutaneous Pulmonary Valves Using Virtual Reality.
Zablah JE, Than J, Browne LP, et al. · J Am Heart Assoc · 2024Research Support, Non-U.S. Gov't
- Transcatheter Pulmonary Valve Implantation in Congenital Heart Diseases: Current Advances and Future Prospectives.
Giordano M, Marzullo R, Gaio G, et al. · Children (Basel) · 2025Review
- Acute Left Main Coronary Artery Compression After Harmony-TPV Implantation.
López-Tejero S, Benson L, Horlick E, et al. · Catheter Cardiovasc Interv · 2025Case Reports
- Acute Leaflet Dysfunction in Transcatheter Pulmonary Valves.
Qadir A, Van Lente L, Al-Khatib Y, et al. · JACC Case Rep · 2026Case Reports
- Harmony Feasibility Trial: Acute and Short-Term Outcomes With a Self-Expanding Transcatheter Pulmonary Valve.
Bergersen L, Benson LN, Gillespie MJ, et al. · JACC Cardiovasc Interv · 2017Clinical Trial, Multicenter Study
- Mini-invasive surgical approach for hybrid pulmonary valve implantation: an option for very high-risk patients.
Castaldi B, Tarzia V, Tarantini G, et al. · Cardiol Young · 2025Case Reports
- 1-Year Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve Clinical Trial Participants.
Gillespie MJ, McElhinney DB, Jones TK, et al. · JACC Cardiovasc Interv · 2023Clinical Trial, Research Support, Non-U.S. Gov't
- Patient Selection Process for the Harmony Transcatheter Pulmonary Valve Early Feasibility Study.
Gillespie MJ, Benson LN, Bergersen L, et al. · Am J Cardiol · 2017
- Transcatheter pulmonary valve implantation in patients with repaired tetralogy of Fallot: International evidence and the current status in Japan.
Kogure T, Inai K, Yamaguchi J · J Cardiol · 2026Review
- Midterm Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve Recipients.
Morray BH, Gillespie MJ, Cheatham JP, et al. · Circ Cardiovasc Interv · 2025Controlled Clinical Trial, Multicenter Study
- Ventricular Arrhythmias After Self-Expanding Transcatheter Pulmonary Valve Replacement: A Report From the SERVE Registry.
Armstrong AK, Goldstein BH, Aboulhosn J, et al. · JACC Clin Electrophysiol · 2026Multicenter Study, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code NPV.
- SAPIEN 3 Transcatheter Pulmonary Valve System with Alterra C Adaptive PrestentEdwards Lifesciences, LLC · PMA 2026
- Edwards Commander Delivery SystemEdwards Lifesciences, LLC · PMA 2023
- Melody Transcatheter Pulmonary ValveMedtronic, Inc. · PMA 2017
- Edwards Alterra Adaptive Prestent SystemEdwards Lifesciences, LLC · PMA 2022
- Harmony Transcatheter Pulmonary ValveMedtronic, Inc. · PMA 2022
- 9600CR CrimperEdwards Lifesciences, LLC · PMA 2022
- Melody TPV SystemMedtronic, Inc. · PMA 2019
- Ensemble II Transcatheter Valve Delivery SystemMedtronic, Inc. · PMA 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.